Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
| Actual shortage: | 247 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OLANZAPINE | 10.0MG | TABLET | Resolved | 2020-10-07 | 2020-12-17 | 125815 |
| APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-10-29 | 2021-11-26 | 148503 |
| APO-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-10-29 | 2021-12-06 | 148506 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2022-04-01 | 2022-04-29 | 157701 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2022-06-06 | 2022-07-11 | 162083 |
| APO-OLANZAPINE | 10MG | TABLET | Resolved | 2022-10-07 | 2022-12-05 | 171422 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2022-10-17 | 2022-12-05 | 171886 |
| APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2022-10-28 | 2022-12-09 | 172901 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2023-01-26 | 2023-02-02 | 182367 |
| APO-OLANZAPINE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-06-02 | 184083 |
| APO-OLANZAPINE | 20MG | TABLET | Resolved | 2023-02-09 | 2023-06-02 | 184097 |
| APO-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-03-02 | 2023-06-02 | 185930 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2023-05-06 | 2023-06-02 | 191874 |
| APO-OLANZAPINE | 10MG | TABLET | Resolved | 2023-07-13 | 2023-09-15 | 198518 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2023-07-27 | 2023-09-28 | 200180 |
| APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-08-18 | 2023-09-28 | 202403 |
| APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-11-06 | 2024-03-01 | 209363 |
| APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-04-12 | 2024-05-24 | 225008 |
| APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-06-13 | 2017-07-31 | 12689 |
| APO-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-08-08 | 2017-08-23 | 18546 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
| APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |
| APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |
| APO-CEFPROZIL | 500MG | TABLET | Discontinued | 2018-04-04 | 2018-10-05 | 44945 |
| APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
| APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
| APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |
| APO-CIPROFLOX | 750MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60388 |
| APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
| APO-CITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60393 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |